Mirae Asset Healthcare Fund

ThematicDirect and Regular plans, Growth and IDCW options

Data as on 30-10-2026

Mirae Asset Healthcare Fund is a Thematic fund run by Mirae Asset Mutual Fund. On 30-09-2026, it managed ₹3,494 Cr of investors' money. In the 3 years to 30-10-2026, its Direct plan returned 23.9% a year and its Regular plan returned 22.1% a year. Its benchmark, BSE Healthcare TRI, returned 23.0% a year over the same 3 years.

NAV (Direct plan): ₹51.66; ▲ 1.07%30-10-2026
NAV (Regular plan): ₹45.49; ▲ 1.07%30-10-2026
Expense ratio: 0.62%Direct2.05%Regular; 0.62%; A year
Riskometer: Very High; Set by the fund house
3 year return: 23.9%Direct22.1%Regular; 23.9%; A year

Mirae Asset Healthcare Fund NAV Today

NAV on 30-10-2026: Direct Plan Growth ₹51.66 (up 1.07% that day); Regular Plan Growth ₹45.49 (up 1.07% that day).

This fund (Direct plan)

₹51.66

Mirae Asset Healthcare Fund Returns vs BSE Healthcare TRI

Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.

Trailing returns
Period	1M	3M	6M	1Y	3Y	5Y	10Y
This fund (Direct)	+1.18%	+0.66%	+14.13%	+18.44%	+23.86%	+16.63%	--
This fund (Regular)	+1.06%	+0.30%	+13.31%	+16.75%	+22.07%	+14.92%	--
BSE Healthcare TRI	+0.24%	−0.99%	+12.80%	+12.37%	+23.01%	+15.61%	+12.48%
Thematic average	−2.09%	−4.52%	+0.86%	−1.22%	+13.76%	+11.62%	--
Best in Thematic	+11.54%	+11.27%	+22.16%	+75.71%	+54.78%	+21.14%	--
Worst in Thematic	−16.05%	−11.74%	−13.97%	−22.44%	−4.46%	+3.65%	--
Rank in Thematic	15/235	25/232	12/232	7/215	7/133	18/96	--

Category rows compare the Direct plans of 235 Thematic funds. Rank 1 is the highest return.

Mirae Asset Healthcare Fund Year-wise Returns

Return of each calendar year
Year	Direct	Regular	BSE Healthcare TRI
2026to date	+20.52%	+19.09%	+15.08%
2025	−1.99%	−3.39%	−2.72%
2024	+41.20%	+39.12%	+44.30%
2023	+36.06%	+34.04%	+37.97%
2022	−10.47%	−11.81%	−11.50%
2021	+28.58%	+26.58%	+21.54%

Mirae Asset Healthcare Fund Rolling Returns

The return of every holding period in the fund's history, not only the one that ends today

Rolling returns

Each point is the yearly return of one 3-year holding period, plotted on the day it ended. There are 1,311 periods, one for each trading day from 05-07-2021 to 30-10-2026.

0%10%20%30%40%

Dec 2018
to
Dec 2021Nov 2019
to
Nov 2022Sept 2020
to
Sept 2023Aug 2021
to
Aug 2024Jul 2022
to
Jul 2025May 2023
to
May 2026

Mirae Asset Healthcare Fund (Direct)BSE Healthcare TRI

Every holding period at a glance

Period	Periods	Median	Lowest	Highest	With a loss	Benchmark median	Beat benchmark
1 year	1,805	19.1%	−11.1%	93.1%	18%	16.9%	67%
2 years	1,561	24.7%	−0.2%	59.1%	0%	21.3%	67%
3 years	1,311	23.2%	14.3%	35.8%	0%	20.9%	74%
5 years	819	23.2%	14.6%	34.3%	0%	19.2%	100%
7 years	326	22.8%	21.1%	26.5%	0%	18.8%	100%

Every SIP holding period at a glance

Period	Periods	Median	Lowest	Highest	With a loss	Benchmark median	Beat benchmark
1 year	88	18.9%	−18.1%	95.7%	18%	14.4%	66%
2 years	76	21.7%	−6.5%	60.9%	5%	21.8%	59%
3 years	64	21.9%	4.8%	47.0%	0%	21.7%	63%
5 years	40	21.2%	14.6%	30.6%	0%	20.6%	75%

Lumpsum: the yearly rate (CAGR) from the NAV on a period's first day to the NAV on its last. SIP: the XIRR of the monthly instalments and their value on the last day. "With a loss" counts the periods that ended below the money put in. "Beat benchmark" counts the periods in which the fund did better than BSE Healthcare TRI over the same days. Past returns do not promise future returns.

Mirae Asset Healthcare Fund Risk

How much it swings, and the falls an investor had to sit through

Risk and return

Measure	Mirae Asset Healthcare Fund (Direct)This fund	BSE Healthcare TRI
Return (CAGR)	+18.44%	+12.37%
Standard deviation	13.74%	13.56%
Sharpe ratio	0.96	0.53
Sortino ratio	1.43	0.77
Maximum drawdown	−9.1% (23-10-2026)	−9.9% (23-10-2026)
Beta	0.99	1.00
Alpha	+6.18%	0.00%

From daily NAVs, 30-10-2025 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta: 1 moves with the benchmark, below 1 moves less. Alpha: return beyond what its beta explains, a year.

Measure	Mirae Asset Healthcare Fund (Direct)This fund	BSE Healthcare TRI
Return (CAGR)	+23.86%	+23.01%
Standard deviation	14.12%	14.12%
Sharpe ratio	1.26	1.20
Sortino ratio	1.80	1.71
Maximum drawdown	−15.9% (28-02-2025)	−16.2% (28-02-2025)
Beta	0.97	1.00
Alpha	+1.28%	0.00%

From daily NAVs, 30-10-2023 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta: 1 moves with the benchmark, below 1 moves less. Alpha: return beyond what its beta explains, a year.

Measure	Mirae Asset Healthcare Fund (Direct)This fund	BSE Healthcare TRI
Return (CAGR)	+16.63%	+15.61%
Standard deviation	13.69%	13.97%
Sharpe ratio	0.79	0.70
Sortino ratio	1.13	1.00
Maximum drawdown	−18.5% (17-06-2022)	−19.6% (17-06-2022)
Beta	0.95	1.00
Alpha	+1.47%	0.00%

From daily NAVs, 29-10-2021 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta: 1 moves with the benchmark, below 1 moves less. Alpha: return beyond what its beta explains, a year.

Measure	Mirae Asset Healthcare Fund (Direct)This fund	BSE Healthcare TRI
Return (CAGR)	+21.71%	+17.13%
Standard deviation	15.56%	16.50%
Sharpe ratio	1.06	0.72
Sortino ratio	1.54	1.02
Maximum drawdown	−20.0% (23-03-2020)	−31.6% (23-03-2020)
Beta	0.92	1.00
Alpha	+5.56%	0.00%

From daily NAVs, 03-07-2018 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta: 1 moves with the benchmark, below 1 moves less. Alpha: return beyond what its beta explains, a year.

Drawdowns

How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.

−40%−30%−20%−10%0%

20192020202120222023202420252026

Mirae Asset Healthcare Fund (Direct)BSE Healthcare TRI

	Worst fall	High before it	Bottom	Back at the high	Time to climb back	Below its high today
Mirae Asset Healthcare Fund (Direct)	−20.0%	20-02-2020	23-03-2020	08-04-2020	16 days	−2.8%
BSE Healthcare TRI	−31.6%	07-09-2018	23-03-2020	05-06-2020	2 months	−3.8%

From the Direct plan's daily NAV since 03-07-2018, adjusted for unit splits, and BSE Healthcare TRI over the same days. "Time to climb back" runs from the bottom to the first day back at the old high.

Mirae Asset Healthcare Fund vs Other Thematic Funds

The five Thematic funds with the best three year return, and this fund. Direct plans.

Fund name	Rank	AUM (Cr)	Exp. ratio	1Y return	3Y return	3Y alpha	3Y beta	3Y Sharpe	3Y Sortino
Nippon India Taiwan Equity Fund	1/133	1,147	1.08%	+75.71%	+54.78%	--	--	1.38	2.03	Compare
HDFC Defence Fund	2/133	11,493	0.90%	+13.79%	+34.76%	−0.18%	0.83	1.12	1.54	Compare
HDFC Pharma and Healthcare Fund	3/133	3,501	1.05%	+23.12%	+30.53%	+8.23%	0.96	1.74	2.49	Compare
SBI Healthcare Opportunities Fund	4/133	5,870	1.01%	+17.12%	+24.60%	+3.61%	0.88	1.42	2.03	Compare
Aditya Birla Sun Life International Equity Fund	5/133	352	2.00%	+13.97%	+24.46%	--	--	1.49	2.16	Compare
Mirae Asset Healthcare Fund	7/133	3,494	0.62%	+18.44%	+23.86%	+1.28%	0.97	1.26	1.80

AUM is each fund's size at the end of its last reported month, from its own portfolio file. We calculate the risk ratios from daily NAVs over the last three years. The risk-free return is what NSE's overnight rate index earned over the same years. Alpha and beta compare each fund with its own benchmark's TRI. "--" means we have no figure: for alpha and beta, no daily series for that benchmark.

Mirae Asset Healthcare Fund Expense Ratio and Costs

What each plan charges a year, in force from 23-10-2026

Plan	Base expense ratio	Brokerage	Transaction costs	Levies and GST	Total expense ratio	Thematic median	Cost rank (1 = cheapest)
Direct	0.45%	0.03%	0.00%	0.14%	0.62%	1.18%	2/235
Regular	1.66%	0.03%	0.00%	0.36%	2.05%	2.41%	35/235

The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, the cost of executing trades, and statutory levies with GST. From AMFI's expense ratio file. Cost rank: where this plan comes when the Thematic funds' plans of the same type are sorted from the lowest total expense ratio to the highest.

Direct vs Regular: what the gap cost

Both plans own the same portfolio, so the difference in what they earned is the Regular plan's extra cost, taken out of its NAV.

Over the last	Regular	Direct	Direct earned more by	₹1 lakh became (Regular)	₹1 lakh became (Direct)
1 year	16.75%	18.44%	1.69%	₹1,16,750	₹1,18,440
3 years	22.07%	23.86%	1.79% a year	₹1,81,898	₹1,90,017
5 years	14.92%	16.63%	1.71% a year	₹2,00,437	₹2,15,800

Returns over more than 1 year are a rate a year (CAGR). ₹1 lakh invested once at the start of each period, valued on the last NAV.

Mirae Asset Healthcare Fund SIP Calculator

What a one-time or monthly investment in this fund would be worth today, from its own NAV history

Growth of an investment

Every month₹

Step up each year

PeriodFor

₹10,000 on the first trading day of every month, from 03-07-2018 to 30-10-2026: 100 instalments, ₹10,00,000 in all.

Investment	Invested	Value now	Gain	Return a year
Direct planMirae Asset Healthcare Fund (Direct)	₹10,00,000	₹25,53,977	₹15,53,977	21.8%
Regular planMirae Asset Healthcare Fund (Regular)	₹10,00,000	₹23,56,792	₹13,56,792	19.9%
BSE Healthcare TRI	₹10,00,000	₹22,59,635	₹12,59,635	19.0%
Category averageCategory average, 235 Thematic funds	₹10,00,000	₹19,61,471	₹9,61,471	15.7%

₹0₹10.0 L₹20.0 L₹30.0 L

20192020202120222023202420252026

Direct planMirae Asset Healthcare Fund (Direct)Regular planMirae Asset Healthcare Fund (Regular)BSE Healthcare TRICategory averageCategory average, 235 Thematic fundsAmount invested

From each plan's published NAV (Growth option), the benchmark's TRI and the category average, over the same days. Return a year: XIRR for a SIP, CAGR for a lumpsum, shown for a year or more. It does not include exit load, stamp duty or tax. Past returns do not promise future returns.

Mirae Asset Healthcare Fund Asset Allocation

Asset allocation as on 30-09-2026

What the fund holds

100.0%Equity

Asset	Fund	Category
Equity	100.0%	94.5%

Market cap of stocks

Market cap	Fund	Category
Large Cap	35.0%	45.7%
Mid Cap	42.1%	19.6%
Small Cap	19.5%	24.1%
Not on AMFI's list	3.4%	2.3%

Share of the whole fund. Category: the average of the Thematic funds that hold stocks. Groups follow AMFI's latest list, as SEBI defines them: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.

Mirae Asset Healthcare Fund Sector Allocation

Sector allocation of the fund's stocks as on 30-09-2026

Largest sectors

Pharmaceuticals & Biotechnology75.8%
Healthcare Services20.5%
Chemicals & Petrochemicals1.9%
Healthcare Equipment & Supplies1.8%

Sector changes

Sector	July 2026	August 2026	September 2026	Change
Pharmaceuticals & Biotechnology	74.8%	75.4%	75.8%	+1.0%
Healthcare Services	22.9%	21.7%	20.5%	−2.4%
Chemicals & Petrochemicals	1.1%	1.1%	1.9%	+0.8%
Healthcare Equipment & Supplies	--	1.4%	1.8%	--

Each sector's share of the fund at the end of each month. The five largest sectors of September 2026. Change: from July 2026 to September 2026, in % of the fund.

Mirae Asset Healthcare Fund Portfolio Holdings

As on 30-09-2026 · 30 holdings · from the fund house's monthly portfolio

Holdings	Sector	Weight%	1M change
Sun Pharmaceutical Industries Ltd.	Pharmaceuticals & Biotechnology	10.15%	0.0%
Divi's Laboratories Ltd.	Pharmaceuticals & Biotechnology	9.79%	−1.1%
Torrent Pharmaceuticals Ltd.	Pharmaceuticals & Biotechnology	6.80%	0.0%
Apollo Hospitals Enterprise Ltd.	Healthcare Services	5.62%	+1.8%
Laurus Labs Ltd.	Pharmaceuticals & Biotechnology	5.51%	0.0%
Dr. Reddy's Laboratories Ltd.	Pharmaceuticals & Biotechnology	4.84%	+12.9%
Glenmark Pharmaceuticals Ltd.	Pharmaceuticals & Biotechnology	4.78%	0.0%
Aurobindo Pharma Ltd.	Pharmaceuticals & Biotechnology	3.78%	0.0%
Alkem Laboratories Ltd.	Pharmaceuticals & Biotechnology	3.76%	+12.6%
IPCA Laboratories Ltd.	Pharmaceuticals & Biotechnology	3.39%	−0.4%
Krishna Institute of Medical Sciences Ltd.	Healthcare Services	3.39%	+6.7%
Aster DM Quality Care Ltd.	Healthcare Services	3.32%	+17.8%
Sai Life Sciences Ltd.	Pharmaceuticals & Biotechnology	3.23%	−8.0%
Onesource Specialty Pharma Ltd.	Pharmaceuticals & Biotechnology	3.01%	0.0%
Fortis Healthcare Ltd.	Healthcare Services	2.94%	0.0%
Dr. Lal Path labs Ltd.	Healthcare Services	2.90%	+0.3%
Gland Pharma Ltd.	Pharmaceuticals & Biotechnology	2.69%	+7.9%
Cipla Ltd.	Pharmaceuticals & Biotechnology	2.63%	0.0%
Eris Lifesciences Ltd.	Pharmaceuticals & Biotechnology	2.39%	0.0%
Max Healthcare Institute Ltd.	Healthcare Services	2.35%	0.0%
Lupin Ltd.	Pharmaceuticals & Biotechnology	2.27%	0.0%
Mankind Pharma Ltd.	Pharmaceuticals & Biotechnology	2.24%	0.0%
Biocon Ltd.	Pharmaceuticals & Biotechnology	2.00%	+2.7%
Molbio Diagnostics Ltd.	Healthcare Equipment & Supplies	1.77%	0.0%
Symbiotec Pharmalab Ltd	Pharmaceuticals & Biotechnology	1.60%	+33.9%
Neogen Chemicals Ltd.	Chemicals & Petrochemicals	1.50%	+108.1%
Anthem Biosciences Ltd.	Pharmaceuticals & Biotechnology	0.93%	−15.6%
Deepak Nitrite Ltd.	Chemicals & Petrochemicals	0.40%	0.0%
Mirae Asset Liquid Fund-Direct Plan-Growth		0.01%
Narayana Hrudayalaya Ltd.	Healthcare Services	0.00%	−99.9%

Mirae Asset Healthcare Fund Stocks Bought and Sold

All changes are between August 2026 and September 2026

Stocks bought and sold in September 2026

Divi's Laboratories Ltd.	Reduced	−1.1%	9.79%
Apollo Hospitals Enterprise Ltd.	Added	+1.8%	5.62%
Dr. Reddy's Laboratories Ltd.	Added	+12.9%	4.84%
Alkem Laboratories Ltd.	Added	+12.6%	3.76%
IPCA Laboratories Ltd.	Reduced	−0.4%	3.39%
Krishna Institute of Medical Sciences Ltd.	Added	+6.7%	3.39%
Aster DM Quality Care Ltd.	Added	+17.8%	3.32%
Sai Life Sciences Ltd.	Reduced	−8.0%	3.23%
Dr. Lal Path labs Ltd.	Added	+0.3%	2.90%
Gland Pharma Ltd.	Added	+7.9%	2.69%
Biocon Ltd.	Added	+2.7%	2.00%
Symbiotec Pharmalab Ltd	Added	+33.9%	1.60%
Neogen Chemicals Ltd.	Added	+108.1%	1.50%
Anthem Biosciences Ltd.	Reduced	−15.6%	0.93%
Narayana Hrudayalaya Ltd.	Reduced	−99.9%	0.00%

A change is counted by the number of shares the fund holds, not by price. A stock can become a smaller part of the fund in a month when the fund bought more of it, if its price fell. Debt papers are left out.

What Mirae Asset Healthcare Fund bought and sold

Mirae Asset Healthcare Fund Portfolio Overlap

Funds with the most similar portfolios, across every fund house and category

Fund	Overlap	Holdings in common
Mirae Asset Nifty 500 Healthcare ETFETF · Mirae Asset	73.5%	24	Compare
Aditya Birla Sun Life Nifty Healthcare ETFETF · Aditya Birla Sun Life	72.4%	18	Compare
DSP Nifty Healthcare Index FundIndex · DSP	72.4%	18	Compare
Axis NIFTY Healthcare ETFETF · Axis	72.4%	18	Compare
ICICI Prudential Nifty Healthcare ETFETF · ICICI Prudential	72.4%	18	Compare
DSP Nifty Healthcare ETFETF · DSP	72.4%	18	Compare
ITI Pharma and Healthcare FundThematic · ITI	66.9%	20	Compare
Bandhan BSE Healthcare Index FundIndex · Bandhan	66.3%	25	Compare

Overlap: for each holding both funds own, the smaller of its two weights, added up. 40% means 40% of each fund's money sits in positions the other also holds. From each fund's latest monthly portfolio, matched by ISIN. Cash and hedged positions are left out. Funds that overlap under 10% are not listed. A high overlap does not make two funds the same: their costs, lock-in and category can differ.

Mirae Asset Healthcare Fund Overview

Fund facts from the scheme summary document, as on 16-10-2026

Expense ratio (Direct): 0.62%
Expense ratio (Regular): 2.05%
Category: Thematic
Risk: Very High
Benchmark: BSE Healthcare TRI
Launch date: 02-07-2018
Minimum investment: ₹5,000
Minimum additional investment: ₹1,000
AUM: ₹3,494.44 Cr (30-09-2026)
Lock in: None
Scheme code (Direct): 143783
ISIN (Direct): INF769K01ED6
Scheme code (Regular): 143785
ISIN (Regular): INF769K01EA2
NAV history: From 03-07-2018, 8.3 years

Exit load: If redeemed within 1 month (30 days) from the date of allotment: 1% If redeemed after 1 month (30 days) from the date of allotment: NIL

Tax on Mirae Asset Healthcare Fund returns

Mirae Asset Healthcare Fund is taxed as an equity fund: 65% or more of it is in Indian stocks.
Units sold within 1 year: the gain is taxed at 20%.
Units held longer: gains above ₹1.25 lakh in a financial year, across all your equity funds and shares, are taxed at 12.5%.
IDCW (dividend) payouts are added to your income and taxed at your slab rate.
A stamp duty of 0.005% is deducted when you invest.

Rules in force from 23-07-2024 (Finance Act 2024). Tax depends on your own income; this is general information, not tax advice.

All plans and options

Plan	Option	NAV	As on
direct	Growth	₹51.66	30-10-2026
direct	IDCW	₹31.115	30-10-2026
regular	Growth	₹45.489	30-10-2026
regular	IDCW	₹26.779	30-10-2026

About Mirae Asset Healthcare Fund

Mirae Asset Healthcare Fund is a mutual fund from Mirae Asset Mutual Fund. Its category is Thematic. It was launched on 02-07-2018. Its benchmark is BSE Healthcare TRI. At the end of September 2026 it held 30 securities.

Fund Manager

Vrijesh Kasera
Fund manager of Mirae Asset Healthcare Fund, since 02-07-2018
Tanmay Mehta
Fund manager of Mirae Asset Healthcare Fund, since 01-04-2025

See all funds of Mirae Asset Mutual Fund

AUM change

September 2026: ₹3,494.44 Cr; −1.71% from August 2026
August 2026: ₹3,555.18 Cr; +3.28% from July 2026
July 2026: ₹3,442.28 Cr; +5.83% from June 2026

AUM moves with money invested or taken out, and with the value of what the fund holds.

Compare Mirae Asset Healthcare Fund with Other Funds

Returns, risk, costs and the stocks they share, side by side

Mirae Asset Healthcare vs Nippon India Taiwan EquityThematic
Mirae Asset Healthcare vs HDFC DefenceThematic
Mirae Asset Healthcare vs HDFC Pharma and HealthcareThematic
Mirae Asset Healthcare vs SBI Healthcare OpportunitiesThematic
Mirae Asset Healthcare vs Aditya Birla Sun Life International EquityThematic
Mirae Asset Healthcare vs Mirae Asset Nifty 500 Healthcare ETF73.5% overlap
Mirae Asset Healthcare vs Aditya Birla Sun Life Nifty Healthcare ETF72.4% overlap
Mirae Asset Healthcare vs DSP Nifty Healthcare Index72.4% overlap

Compare with any other fund

Frequently Asked Questions for Mirae Asset Healthcare Fund

What is the current NAV of Mirae Asset Healthcare Fund?

The Direct plan NAV is ₹51.66. The Regular plan NAV is ₹45.489, as on 30-10-2026.

What are the returns of Mirae Asset Healthcare Fund?

The Direct plan returned +18.44% in 1 year, +23.86% a year over 3 years, +16.63% a year over 5 years. The Regular plan returned +16.75% in 1 year, +22.07% a year over 3 years, +14.92% a year over 5 years. These figures are as on 30-10-2026.

What is the expense ratio of Mirae Asset Healthcare Fund?

The Direct plan charges 0.62% a year. The Regular plan charges 2.05% a year. This is the figure the fund house reported to AMFI, in force from 23-10-2026.

What is the AUM of Mirae Asset Healthcare Fund?

Mirae Asset Healthcare Fund managed ₹3,494.44 Cr on 30-09-2026, as its fund house reported in its monthly portfolio.

What are the top holdings of Mirae Asset Healthcare Fund?

At the end of September 2026 the largest holdings were SUNPHARMA (10.15%), DIVISLAB (9.79%), TORNTPHARM (6.80%), APOLLOHOSP (5.62%), LAURUSLABS (5.51%). The fund held 30 securities in all.

What did Mirae Asset Healthcare Fund buy and sell in September 2026?

It added shares in 10. It reduced 5.

How do I invest in Mirae Asset Healthcare Fund?

Through Mirae Asset Mutual Fund's website or app, a mutual fund distributor, or an investment platform. Choose the Direct plan to pay no distributor commission, or the Regular plan to invest through a distributor. The first investment is at least ₹5,000. You can invest once or through a monthly SIP.

Who is the fund manager of Mirae Asset Healthcare Fund?

Vrijesh Kasera (since 02-07-2018), Tanmay Mehta (since 01-04-2025).

Sources: NAV and expense ratio from AMFI. Holdings from the fund house's monthly portfolio statement. Fund facts from its scheme summary document, as on 16-10-2026.

This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.